GALT

Galectin Therapeutics Inc. - Common Stock (GALT)

About Galectin Therapeutics Inc. - Common Stock (GALT)

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Details

Daily high

$4.02

Daily low

$3.85

Price at open

$3.91

52 Week High

$7.13

52 Week Low

$2.02

Market cap

392.3M

Dividend yield

Volume

258,378

Avg. volume

358,036

P/E ratio

-9.05

Galectin Therapeutics Inc. - Common Stock News